• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Pediatrics

Protocol-driven Neonatal Abstinence Syndrome care effective

byLeah Carr, MDandWilliam Raszka, MD
July 28, 2014
in Pediatrics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Among infants managed for neonatal abstinence syndrome (NAS), strict weaning protocols were associated with significantly shorter opioid treatment duration and hospital stay compared to those treated without strict weaning parameters.

2. Length of hospital stay and treatment duration did not differ significantly between groups of infants treated initially with morphine versus methadone.

Evidence Rating Level: 2 (Good)

Study Rundown: As more infants are born to opioid-dependent mothers, neonatal abstinence syndrome (NAS) is on the rise. NAS is a condition marked by a variety of deficits that include autonomic dysfunction and attention. While many different methods for managing NAS exist, there is no agreement on how best to treat the condition. Researchers conducting the current study aimed to examine variations in NAS management to determine if standardized pharmacologic protocols were associated with better primary outcome measures, namely shorter opioid treatment period and hospital stay. Study findings indicated that infants treated on strict weaning protocols were more likely to have shorter opioid treatment durations and shorter hospital stays. This study was limited by estimation of treatment days for those infants discharged with outpatient narcotic prescriptions and included only infants treated at select neonatology groups in the state of Ohio. However, its large sample size and significant findings indicate that efficient, cost-effective care for infants with NAS may lie in the implementation and monitoring of infants on standardized weaning protocols, regardless of the narcotic initially used.

Click to read the study, published today in Pediatrics

Relevant Reading: Variation in treatment of neonatal abstinence syndrome in US Children’s Hospitals, 2004-2011

RELATED REPORTS

Vibration may have role in treating neonatal opioid withdrawal syndrome

Neonatal abstinence syndrome linked to educational disabilities

AAP supports public health interventions for opioid-dependent pregnant women

Study Author, Eric S. Hall, PhD, talks to 2 Minute Medicine: Assistant Professor, University of Cincinnati Department of Pediatrics.

“Although there remains a lack of consensus regarding the optimal pharmacologic treatment for NAS, this study demonstrates that regardless of treatment opioid, improved outcomes may be achieved through standardizing treatment and weaning guidelines.”

In-Depth [retrospective cohort study]: Files from a total of 547 infants (mean gestational age = 38.3 + 1.6 weeks, 52.8% male) treated with opioids for NAS during January 2012 through July 2013 were reviewed and categorized by adherence to an established opiate weaning protocol (N = 130 not on standardized protocols, N = 417 on strict protocol). Patient files were taken from infants cared for by 6 neonatology groups, representing 20 hospitals in Ohio. Patient care on strict protocols included explicit opioid dosing or weaning strategies. Outcomes, including time to discharge and exact or estimated length of required opioid treatment, were compared between groups using mixed effects models. In addition, secondary analyses examined outcomes of initial treatment of NAS with methadone or morphine among infants treated on established protocols. When compared to infants treated on strict protocols, those on less stringent management plans were treated for a significantly longer time (32.1 days vs. 17.7 days, P < .0001) and had longer hospital stays (32.1 days vs. 22.7 days, P < .004). Among the 6 neonatology groups studied, 3 weaned using morphine and 3 weaned using methadone. No significant differences in length of treatment, hospital stay, or likelihood to require secondary therapy were observed between infants on protocols involving either morphine or methadone; however, those treated on a morphine taper were more likely to have a longer duration of adjuvant phenobarbital therapy.

More from this author: High prevalence of pediatric dosing errors suggests unit standardization; Risk factors for sleep-related death may differ by age; Delayed umbilical cord clamping associated with potential antioxidant effect; Antibiotic GBS prophylaxis linked to decreased early-onset neonatal infection [Pediatrics Classics Series]; Caregiver-mediated autism interventions effective for low-resourced families

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: neonatal abstinence syndrome
Previous Post

Shorter surveillance follow-up for stage I seminoma may be sufficient

Next Post

Impaired brain growth in preterm infants linked with delayed cognitive development

RelatedReports

Large proportion of late preterm infants and older admitted to the NICU
Chronic Disease

Vibration may have role in treating neonatal opioid withdrawal syndrome

June 1, 2023
AAP recommends disaster preparedness measures for children
Obstetrics

Neonatal abstinence syndrome linked to educational disabilities

August 30, 2018
Risk factors identified for adverse pregnancy outcomes in patients with stable lupus
Obstetrics

AAP supports public health interventions for opioid-dependent pregnant women

February 27, 2017
Increasing C-section room temperature linked to reduced neonatal, maternal hypothermia
Pediatrics

Standardized protocols improve quality of care for Neonatal Abstinence Syndrome

April 15, 2016
Next Post
Buccal administration of dextrose gel effective for neonatal hypoglycemia

Impaired brain growth in preterm infants linked with delayed cognitive development

Study lends support for interferon-free treatment of hepatitis C

Novel pill-only regimens effective against hepatitis C [COSMOS and HALLMARK-DUAL study]

Pro-vaccine messages not associated with increased vaccination intent

AAP updates meningococcal vaccine recommendations

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Weighted vests and resistance training confer similar outcomes for bone density in the elderly
  • Breast cancer survivors may have a lower risk of Alzheimer’s dementia
  • Evaluating scar outcomes in pediatric burn patients following skin grafting 
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.